Atypical teratoid rhabdoid tumor other diagnostic studies

	Atypical teratoid rhabdoid tumor Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Atypical Teratoid Rhabdoid Tumor from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Atypical teratoid rhabdoid tumor other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Atypical teratoid rhabdoid tumor other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Atypical teratoid rhabdoid tumor other diagnostic studies
CDC on Atypical teratoid rhabdoid tumor other diagnostic studies
Atypical teratoid rhabdoid tumor other diagnostic studies in the news
Blogs on Atypical teratoid rhabdoid tumor other diagnostic studies
Directions to Hospitals Treating Atypical teratoid rhabdoid tumor
Risk calculators and risk factors for Atypical teratoid rhabdoid tumor other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Other diagnostic studies for atypical teratoid rhabdoid tumor include biopsy (definitive diagnostic test), fluorescence in situ hybridization (abnormalities of chromosome 22q11.2), and immunohistochemistry (loss of INI-1 staining in the neoplastic cells).^[1]^[2]

Other Diagnostic Studies

Biopsy

Biopsy is performed for definitive diagnosis of atypical teratoid rhabdoid tumor.^[1]

Fluorescent In Situ Hybridization

Fluorescence in situ hybridization demonstrates abnormalities of chromosome 22q11.2.

Immunohistochemistry

Immunohistochemistry studies reveal the loss of INI-1 staining in the neoplastic cells confirming the diagnosis of Aatypical teratoid rhabdoid tumor.^[2]

References

↑ ^1.0 ^1.1 Diagnostic evaluation of atypical teratoid rhabdoid tumor. National Cancer Institute 2015. http://www.cancer.gov/types/brain/hp/child-cns-atrt-treatment-pdq#link/_113_toc. Accessed on December 16, 2015
↑ ^2.0 ^2.1 Udaka, Y. T.; Shayan, K.; Chuang, N. A.; Crawford, J. R. (2013). "Atypical Presentation of Atypical Teratoid Rhabdoid Tumor in a Child". Case Reports in Oncological Medicine. 2013: 1–4. doi:10.1155/2013/815923. ISSN 2090-6706.

Template:WH Template:WS

[biopsyatrt1-1] 1.0 ^1.1 Diagnostic evaluation of atypical teratoid rhabdoid tumor. National Cancer Institute 2015. http://www.cancer.gov/types/brain/hp/child-cns-atrt-treatment-pdq#link/_113_toc. Accessed on December 16, 2015

[UdakaShayan2013-2] 2.0 ^2.1 Udaka, Y. T.; Shayan, K.; Chuang, N. A.; Crawford, J. R. (2013). "Atypical Presentation of Atypical Teratoid Rhabdoid Tumor in a Child". Case Reports in Oncological Medicine. 2013: 1–4. doi:10.1155/2013/815923. ISSN 2090-6706.

[1]

[2]